VD's Model Portfolio & Discussion Thread Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VD's Model Portfolio & Discussion Thread

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Rocketman who wrote (784)	5/23/1997 5:33:00 PM
From: squetch	of 9719

Rman, MATX should get a bump and be helpful to the model. I have none in the PA sad to say. I was behind following you guys on MATX thread. MATX's Injectable gels seem to work well because localizes in tumor and cuts blood flow. Did you say flourouracil is a nasty compound? Rman have you looked at PCYC. They have a compound based on expanded porphyrins. A long story short, these compounds in testing seem to localize in tumors. When hit w/ an energy source, singlet oxygen burns tumor away. I have seen only seen insignificant side-effects to date. Alas, MATX has approved products. PCYC has none. An approval in hand is worth two in trial. squetch

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next